Preprint
Article
Risk Factors of Infection in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone (Rd) Regimen: Real-life Results of a Large Single-center Study
Submitted:
31 August 2022
Posted:
01 September 2022
You are already at the latest version
A peer-reviewed article of this preprint also exists.
Abstract
Keywords:
Subject:
Medicine and Pharmacology - Oncology and OncogenicsCopyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Alerts
MDPI Initiatives
Important Links
© 2025 MDPI (Basel, Switzerland) unless otherwise stated